Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis

Multiple Sclerosis

Volumn 22, Issue 1, 2016, Pages 36-42

  Modica, Claire M ^a   Bergsland, Niels ^a,b   Dwyer, Michael G ^a   Ramasamy, Deepa P ^a   Carl, Ellen ^a   Zivadinov, Robert ^a,c   Benedict, Ralph H B ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

cognitive impairment; cognitive reserve; MRI; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; NATALIZUMAB;

ADULT; ARTICLE; BRAIN ATROPHY; COGNITION; COGNITION ASSESSMENT; COGNITIVE DECLINE; COGNITIVE RESERVE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGICAL ASPECT; SUBCORTEX; ATROPHY; COGNITION DISORDERS; COMPLICATION; MEMORY DISORDERS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTECTION; PSYCHOMOTOR PERFORMANCE; AMYGDALA; BRAIN SIZE; CALIFORNIA VERBAL LEARNING TEST; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; COGNITIVE DEFECT; COGNITIVE PROCESSING SPEED; EXPANDED DISABILITY STATUS SCALE; GLOBUS PALLIDUS; INTRACRANIAL VOLUME; NERVOUS SYSTEM PARAMETERS; NUCLEUS ACCUMBENS; SCORING SYSTEM; SUBCORTICAL GRAY MATTER ATROPHY; SYMBOL DIGIT MODALITIES TEST; THALAMUS;

ADULT; ATROPHY; COGNITION DISORDERS; COGNITIVE RESERVE; FEMALE; FOLLOW-UP STUDIES; GRAY MATTER; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTECTIVE FACTORS; PSYCHOMOTOR PERFORMANCE;

EID: 84951000497     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515579443     Document Type: Article

References (35)

1. Chiaravalloti ND, DeLuca J,. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151.
2. Benedict RH, Morrow S, Rodgers J, et al. Characterizing cognitive function during relapse in multiple sclerosis. Mult Scler J 2014: 20: 1745-1752.
3. Filippi M, Rocca MA, Benedict RH, et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010; 75: 2121-2128.
4. Strober LB, Christodoulou C, Benedict RH, et al. Unemployment in multiple sclerosis: the contribution of personality and disease. Mult Scler 2012; 18: 647-653.
5. Schoonheim MM, Popescu V, Rueda Lopes FC, et al. Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 2012; 79: 1754-1761.
6. Houtchens MK, Benedict RHB, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007; 69: 113-123.
7. Batista S, Zivadinov R, Hoogs M, et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012; 259: 139-146.
8. Satz P,. Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology 1993; 7: 273-295.
9. Stern Y,. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20: S69-74.
10. Benedict RH, Morrow SA, Weinstock Guttman B, et al. Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. J Int Neuropsychol Soc 2010; 16: 829-835.
11. Sumowski JF, Wylie GR, Deluca J, et al. Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain 2010; 133: 362-374.
12. Schwartz CE, Snook E, Quaranto B, et al. Cognitive reserve and patient-reported outcomes in multiple sclerosis. Mult Scler 2013; 19: 87-105.
13. Courchesne E, Chisum HJ, Townsend J, et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 2000; 216: 672-682.
14. Sumowski JF, Rocca MA, Leavitt VM, et al. Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS. Neurology 2014; 82: 1776-1783.
15. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the €McDonald Criteria€. Ann Neurol 2005; 58: 840-846.
16. Smith SM, DeStefano N, Jankinson M, et al. Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001; 25: 466-475.
17. Zivadinov R, Rudick RA, De Masi R, et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001; 57: 1239-1247.
18. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002; 17: 479-489.
19. Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011; 56: 907-922.
20. Gelineau-Morel R, Tomassini V, Jenkinson M, et al. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Human Brain Mapping 2012; 33: 2802-2814.
21. Langodon DW, Amato MP, Boringa J, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Multiple Sclerosis Journal 2012; 18: 891-898.
22. Smith A,. Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services, 1982.
23. Delis DC, Kramer JH,. California Verbal Learning Test: CvLT-II; Adult Version; Manual, 2000.
24. Benedict R,. Brief visuospatial memory test-revised. Odessa, FL: Psychological Assessment Resources, 1997.
25. Amato MP, Razzolini L, Goretti B, et al. Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. Neurology 2013; 80: 1728-1733.
26. Loitfelder M, Fazekas F, Koschutnig K, et al. Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis-insights from a longitudinal FMRI study. PloS one 2014; 9: e93715.
27. Benedict RH, Smerbeck A, Parikh R, et al. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials. Mult Scler J 2012; 18: 1320-1325.
28. Cohen JA, Reingold SC, Polman CH, et al. Disability outcome measures in multiple sclerosis clinical trials: Current status and future prospects. The Lancet Neurol 2012; 11: 467-476.
29. Zivadinov R, Sepcic J, Nasuelli D, et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70: 773-780.
30. Fisher E, Lee JC, Nakamura K, et al. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008; 64: 255-265.
31. Zivadinov R, Bergsland N, Dolezal O, et al. Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years. Am J Neuroradiol 2013; 34: 1931-1939.
32. Sumowski JF, Rocca MA, Leavitt VM, et al. Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it. Neurology 2013; 80: 2186-2193.
33. Booth AJ, Rodgers JD, Schwartz CE, et al. Active cognitive reserve influences the regional atrophy to cognition link in multiple sclerosis. J Intl Neuropsychol Soc 2013; 19.
34. Amato M, Goretti B, Viterbo R, et al. Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial. Mult Scler J 2014; 20: 91-98.
35. Sandroff BM, Klaren RE, Pilutti LA, et al. Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis. J Neurol 2014; 261: 363-372.